Evidence map›Paper›PMID 35386194›Full record

ReviewFrontiers in cell and developmental biology2022

Single-Cell Multiomics Techniques: From Conception to Applications.

Maria A Dimitriu, Irina Lazar-Contes, Martin Roszkowski, Isabelle M Mansuy

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Combating Root-Knot Nematodes (Plants (Basel, Switzerland) · 2025
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Multi-omics analysis in developmental bone biology.The Japanese dental science review · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Maria A DimitriuLaboratory of Neuroepigenetics, Brain Research Institute, University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Irina Lazar-ContesLaboratory of Neuroepigenetics, Brain Research Institute, University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Martin RoszkowskiLaboratory of Neuroepigenetics, Brain Research Institute, University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.
Isabelle M MansuyLaboratory of Neuroepigenetics, Brain Research Institute, University of Zurich and Institute for Neuroscience, ETH Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent advances in methods for single-cell analyses and barcoding strategies have led to considerable progress in research. The development of multiplexed assays offers the possibility to conduct parallel analyses of multiple factors and processes for comprehensive characterization of cellular and molecular states in health and disease. These technologies have expanded extremely rapidly in the past years and constantly evolve and provide better specificity, precision and resolution. This review summarizes recent progress in single-cell multiomics approaches, and focuses, in particular, on the most innovative techniques that integrate genome, epigenome and transcriptome profiling. It describes the methodologies, discusses their advantages and limitations, and explains how they have been applied to studies on cell heterogeneity and differentiation, and epigenetic reprogramming.

Indexed as

chromatin accessibilityepigenomicsgenomicsmultiomicssingle-celltranscriptomics

Identifiers

PMID35386194
PMCPMC8979110

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.